Valuation: BioHarvest Sciences Inc.

Market Cap 41.94M 36.13M 34.21M 31.01M 58.18M 4.01B 58.47M 406M 156M 2.04B 157M 154M 6.44B P/E 2026 *
-3.51x
P/E 2027 * -5.52x
Enterprise Value 41.94M 36.13M 34.21M 31.01M 58.18M 4.01B 58.47M 406M 156M 2.04B 157M 154M 6.44B EV / Sales 2026 *
1.12x
EV / Sales 2027 * 0.85x
Free-Float
85.23%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 68 29/04/2026
Director of Finance/CFO - 28/10/2024
Chief Operating Officer 65 19/04/2023
Director TitleAgeSince
Chairman 68 27/09/2018
Director/Board Member 67 27/09/2018
Director/Board Member 84 07/02/2019
Change 5-day change 1-year change 3-year change Capi.($)
+6.06%-2.94% - - 41.94M
+0.71%-0.51%-13.95%-4.41% 13.4B
+0.73%-2.36%-33.00%-56.70% 4.78B
+1.37%-4.28%-4.54%-4.70% 4.36B
+1.25%-3.09%-10.58%-30.50% 3.78B
+0.29%-3.70%-25.45%+1.79% 3.43B
+2.46%-1.28%-1.97%-2.04% 3.41B
-0.07%-4.89%-13.78%+4.32% 3.12B
+1.11%-1.55%-23.77%-16.93% 2.27B
+0.05%-2.76%-29.76%-19.88% 1.63B
Average +1.40%-2.38%-17.42%-14.34% 4.47B
Weighted average by Cap. +0.89%-1.78%-16.03%-13.05%

Financials

2026 *2027 *
Net sales 37.42M 32.24M 30.53M 27.67M 51.91M 3.57B 52.17M 363M 139M 1.82B 141M 137M 5.75B 49.59M 42.73M 40.46M 36.67M 68.8M 4.74B 69.14M 481M 185M 2.41B 186M 182M 7.62B
Net income -12.02M -10.36M -9.81M -8.89M -16.67M -1.15B -16.76M -116M -44.78M -584M -45.14M -44.15M -1.85B -7.65M -6.59M -6.24M -5.66M -10.61M -731M -10.66M -74.1M -28.5M -372M -28.72M -28.09M -1.17B
Net Debt - -
Logo BioHarvest Sciences Inc.
BioHarvest Sciences Inc. is a Canada-based botanical synthesis company. The Company leverages its technology platform to grow plant-based compounds, without the need to grow the underlying plant. It is leveraging its botanical synthesis technology to develop science-based therapeutic solutions within two major business verticals; as a contract development and manufacturing organization (CDMO) on behalf of customers seeking plant-based compounds, and as a creator of nutraceutical health and wellness products, which include dietary supplements. It delivers phytochemicals such as age-defying antioxidants and polyphenols used for wellness. Its product pipeline is focused on polyphenols, which include grape cells, olive cells, and pomegranate cells. Its process involves selecting the specific plant cells that can create the targeted ingredients. It offers VINIA, which is a nutraceutical containing the entire matrix of polyphenols contained in red grapes, including Piceid resveratrol.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.850USD
Average target price
10.50USD
Spread / Average Target
+467.57%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!